Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AWX4
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0018193 | peptidyl-amino acid modification | 5 | 9 |
GO:0018208 | peptidyl-proline modification | 6 | 9 |
GO:0019538 | protein metabolic process | 3 | 9 |
GO:0036211 | protein modification process | 4 | 9 |
GO:0043170 | macromolecule metabolic process | 3 | 9 |
GO:0043412 | macromolecule modification | 4 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 9 |
GO:0006457 | protein folding | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 9 |
GO:0003824 | catalytic activity | 1 | 9 |
GO:0016853 | isomerase activity | 2 | 9 |
GO:0016859 | cis-trans isomerase activity | 3 | 9 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 9 |
GO:0005488 | binding | 1 | 1 |
GO:0016018 | cyclosporin A binding | 4 | 1 |
GO:0033218 | amide binding | 2 | 1 |
GO:0042277 | peptide binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 226 | 228 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.719 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.603 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.494 |
DEG_SPOP_SBC_1 | 9 | 13 | PF00917 | 0.463 |
DOC_PP1_RVXF_1 | 193 | 200 | PF00149 | 0.296 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.368 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.418 |
DOC_USP7_UBL2_3 | 112 | 116 | PF12436 | 0.296 |
DOC_USP7_UBL2_3 | 50 | 54 | PF12436 | 0.551 |
DOC_WW_Pin1_4 | 90 | 95 | PF00397 | 0.337 |
LIG_14-3-3_CanoR_1 | 168 | 174 | PF00244 | 0.355 |
LIG_14-3-3_CanoR_1 | 8 | 18 | PF00244 | 0.432 |
LIG_BRCT_BRCA1_1 | 169 | 173 | PF00533 | 0.261 |
LIG_BRCT_BRCA1_1 | 175 | 179 | PF00533 | 0.261 |
LIG_Clathr_ClatBox_1 | 71 | 75 | PF01394 | 0.384 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.493 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.362 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.346 |
LIG_LIR_Gen_1 | 12 | 21 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 176 | 187 | PF02991 | 0.355 |
LIG_LIR_Gen_1 | 22 | 29 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 236 | 242 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.264 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.301 |
LIG_MLH1_MIPbox_1 | 175 | 179 | PF16413 | 0.261 |
LIG_Pex14_2 | 15 | 19 | PF04695 | 0.478 |
LIG_PTB_Apo_2 | 119 | 126 | PF02174 | 0.355 |
LIG_SH2_CRK | 161 | 165 | PF00017 | 0.337 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.386 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.518 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.485 |
LIG_SUMO_SIM_par_1 | 82 | 87 | PF11976 | 0.337 |
LIG_UBA3_1 | 71 | 76 | PF00899 | 0.388 |
LIG_WW_3 | 46 | 50 | PF00397 | 0.729 |
MOD_CDK_SPK_2 | 90 | 95 | PF00069 | 0.337 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.276 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.148 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.355 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.563 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.415 |
MOD_Cter_Amidation | 32 | 35 | PF01082 | 0.425 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.223 |
MOD_GlcNHglycan | 218 | 222 | PF01048 | 0.473 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.537 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.567 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.337 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.382 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.287 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.423 |
MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.283 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.485 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.287 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.341 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.449 |
MOD_PIKK_1 | 173 | 179 | PF00454 | 0.374 |
MOD_PKA_2 | 123 | 129 | PF00069 | 0.281 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.296 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.261 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.490 |
MOD_Plk_1 | 235 | 241 | PF00069 | 0.406 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.523 |
MOD_ProDKin_1 | 90 | 96 | PF00069 | 0.337 |
TRG_DiLeu_BaEn_1 | 32 | 37 | PF01217 | 0.513 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.563 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.537 |
TRG_ENDOCYTIC_2 | 81 | 84 | PF00928 | 0.355 |
TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.436 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3D1 | Leptomonas seymouri | 66% | 100% |
A0A0N0P523 | Leptomonas seymouri | 32% | 88% |
A0A0S4J351 | Bodo saltans | 29% | 91% |
A0A1X0ND98 | Trypanosomatidae | 40% | 100% |
A0A1X0NXG7 | Trypanosomatidae | 29% | 93% |
A0A3R7RE54 | Trypanosoma rangeli | 31% | 94% |
A0A3S5H7U6 | Leishmania donovani | 26% | 94% |
A0A3S7WXF4 | Leishmania donovani | 31% | 82% |
A0A3S7WYD9 | Leishmania donovani | 90% | 100% |
A4HCL8 | Leishmania braziliensis | 27% | 82% |
A4HDL1 | Leishmania braziliensis | 78% | 100% |
A4HLM4 | Leishmania braziliensis | 28% | 100% |
A4I042 | Leishmania infantum | 31% | 82% |
A4I0X0 | Leishmania infantum | 90% | 100% |
A4I935 | Leishmania infantum | 26% | 94% |
C9ZUX8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 80% |
C9ZWH7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9B400 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 95% |
P29117 | Rattus norvegicus | 31% | 100% |
P52011 | Caenorhabditis elegans | 30% | 100% |
Q38867 | Arabidopsis thaliana | 31% | 100% |
Q38900 | Arabidopsis thaliana | 30% | 100% |
Q4G338 | Haemonchus contortus | 32% | 75% |
Q4Q424 | Leishmania major | 27% | 100% |
Q4QAK0 | Leishmania major | 92% | 100% |
Q4QBH1 | Leishmania major | 31% | 82% |
Q99KR7 | Mus musculus | 30% | 100% |
V5B2A0 | Trypanosoma cruzi | 31% | 94% |